Metaproterenol Inh Soln Rx
Generic Name and Formulations:
Metaproterenol sulfate 0.4%, 0.6%.
Various generic manufacturers
Indications for Metaproterenol Inh Soln:
By intermittent positive pressure breathing apparatus (IPPB): 2.5mL 3–4 times daily, up to every 4 hrs.
Arrhythmias associated with tachycardia.
Avoid excessive use. Hypertension. Cardiovascular disease. CHF. Hyperthyroidism. Diabetes. Seizure disorders. Pregnancy (Cat.C). Nursing mothers.
Avoid other aerosol β-agonists. Potentiated by sympathomimetics, tricyclics, MAOIs.
Tachycardia, nervousness, tremor, headache, dizziness, GI upset, hypertension, paradoxical bronchospasm, cough, bad taste.
Inh soln, tabs, syrup—contact supplier.
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally